Literature DB >> 15811958

Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.

Yasunari Takada1, Michael Andreeff, Bharat B Aggarwal.   

Abstract

Indole-3-carbinol, found in Brassica species vegetables (such as cabbage, cauliflower, and brussels spouts), exhibits antitumor effects through poorly defined mechanisms. Because several genes that regulate apoptosis, proliferation, and metastasis are regulated by nuclear factor-kappaB (NF-kappaB), we postulated that indole-3-carbinol must mediate its activity through NF-kappaB modulation. We demonstrated that indole-3-carbinol suppressed constitutive NF-kappaB activation and activation induced by tumor necrosis factor (TNF), interleukin-1beta (IL-1beta), phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide (LPS), and cigarette smoke; the suppression was not cell type specific, because activation was inhibited in myeloid, leukemia, and epithelial cells. This activation correlated with the sequential suppression of the IkappaBalpha kinase, IkappaBalpha phosphorylation, IkappaBalpha ubiquitination, IkappaBalpha degradation, p65 phosphorylation, p65 nuclear translocation, p65 acetylation, and NF-kappaB-dependent reporter gene expression. The NF-kappaB-regulated gene products cyclin D1, cyclooxygenase-2 (COX-2), matrix metalloproteinase-9 (MMP-9), survivin, inhibitor-of-apoptosis protein-1 (IAP1), IAP2, X chromosome-linked IAP (XIAP), Bcl-2, Bfl-1/A1, TNF receptor-associated factor-1 (TRAF1), and Fas-associated death domain protein-like interleukin-1beta-converting enzyme inhibitory protein (FLIP) were all down-regulated by indole-3-carbinol. This down-regulation led to the potentiation of apoptosis induced by cytokines and chemotherapeutic agents. Indole-3-carbinol suppressed constitutive NF-kappaB activation in mononuclear cells derived from bone marrow of acute myelogenous leukemia patients, and this correlated with inhibition of cell growth. Overall, our results indicated that indole-3-carbinol inhibits NF-kappaB and NF-kappaB-regulated gene expression and that this mechanism may provide the molecular basis for its ability to suppress tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15811958      PMCID: PMC1895177          DOI: 10.1182/blood-2004-12-4589

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  60 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.

Authors:  Lynne M Howells; Barbara Gallacher-Horley; Catherine E Houghton; Margaret M Manson; E Ann Hudson
Journal:  Mol Cancer Ther       Date:  2002-11       Impact factor: 6.261

3.  Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis.

Authors:  Yiwei Li; Xingli Li; Fazlul H Sarkar
Journal:  J Nutr       Date:  2003-04       Impact factor: 4.798

4.  Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.

Authors:  Hien T Le; Charlene M Schaldach; Gary L Firestone; Leonard F Bjeldanes
Journal:  J Biol Chem       Date:  2003-03-27       Impact factor: 5.157

Review 5.  Nuclear transcription factor-kappaB as a target for cancer drug development.

Authors:  A Garg; B B Aggarwal
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

6.  The nuclear localization of NFkappaB and p53 is positively correlated with HPV16 E7 level in laryngeal squamous cell carcinoma.

Authors:  Jing Du; George G Chen; Alexander C Vlantis; Hu Xu; Raymond K Y Tsang; Andrew C van Hasselt
Journal:  J Histochem Cytochem       Date:  2003-04       Impact factor: 2.479

7.  Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer.

Authors:  B T Ashok; Y G Chen; X Liu; V P S Garikapaty; R Seplowitz; J Tschorn; K Roy; A Mittelman; R K Tiwari
Journal:  Eur J Cancer Prev       Date:  2002-08       Impact factor: 2.497

8.  Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP.

Authors:  Kye-Im Jeon; Jeong-Keun Rih; Hee-Jeong Kim; Yong J Lee; Chi-Heum Cho; Itzhak D Goldberg; Eliot M Rosen; Insoo Bae
Journal:  FEBS Lett       Date:  2003-06-05       Impact factor: 4.124

9.  Anti-metastatic activities of all-trans retinoic acid, indole-3-carbinol and (+)-catechin in Dunning rat invasive prostate adenocarcinoma cells.

Authors:  Joseph O Nwankwo
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

10.  Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.

Authors:  Alok C Bharti; Nicholas Donato; Sujay Singh; Bharat B Aggarwal
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

View more
  29 in total

Review 1.  Cancer and diet: How are they related?

Authors:  Bokyung Sung; Sahdeo Prasad; Vivek R Yadav; Afsaneh Lavasanifar; Bharat B Aggarwal
Journal:  Free Radic Res       Date:  2011-06-09

2.  [Aspects of traditional Indian medicine (Ayurveda) in urology].

Authors:  J Mani; S Kumar; G J Dobos; A Haferkamp
Journal:  Urologe A       Date:  2012-12       Impact factor: 0.639

3.  Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells.

Authors:  Majid Safa; Behnaz Tavasoli; Rima Manafi; Fatemeh Kiani; Meysam Kashiri; Saber Ebrahimi; Ahmad Kazemi
Journal:  Tumour Biol       Date:  2015-01-15

4.  Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.

Authors:  Xinmei Wang; Hongyan He; Yuanzhi Lu; Wei Ren; Kun-Yu Teng; Chi-Ling Chiang; Zhaogang Yang; Bo Yu; Shuhao Hsu; Samson T Jacob; Kalpana Ghoshal; L James Lee
Journal:  Biochim Biophys Acta       Date:  2014-10-25

5.  Flice inhibitory protein is associated with the survival of neonatal neutrophils.

Authors:  Ramachandran Rashmi; Patricia M Schnulle; Allison C Maddox; Eric S Armbrecht; Joyce M Koenig
Journal:  Pediatr Res       Date:  2011-10       Impact factor: 3.756

6.  Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.

Authors:  Crystal N Marconett; Shyam N Sundar; Kevin M Poindexter; Theresa R Stueve; Leonard F Bjeldanes; Gary L Firestone
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

7.  Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice.

Authors:  Fekadu Kassie; Stephen Kalscheuer; Ilze Matise; Linan Ma; Tamene Melkamu; Pramod Upadhyaya; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2009-07-22       Impact factor: 4.944

Review 8.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

Review 9.  Indole-3-carbinol as a chemopreventive and anti-cancer agent.

Authors:  Jing-Ru Weng; Chen-Hsun Tsai; Samuel K Kulp; Ching-Shih Chen
Journal:  Cancer Lett       Date:  2008-03-07       Impact factor: 8.679

10.  Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol.

Authors:  Yoshiaki Machijima; Chie Ishikawa; Shigeki Sawada; Taeko Okudaira; Jun-nosuke Uchihara; Yuetsu Tanaka; Naoya Taira; Naoki Mori
Journal:  Retrovirology       Date:  2009-01-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.